Clinical Trial Update: Atezolizumab + Stereotactic Radiation in Triple-negative Breast Cancer and Brain Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing atezolizumab plus stereotactic radiation for triple-negative breast cancer with brain metastases has completed enrollment, and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2023-12-22